Ctimpsolutions understand the challenges sponsors or CROs face with Investigational Medicinal Products from manufacturing to CTA approval. This is why we believe that expert advice can help overcome these challenges and mitigate risks particularly for studies involving novel products. Whichever stage you are in your clinical trial, whether it's as early as pre-clinical work-up or as late as CTA submission, ctimpsolutions can work with you and optimise your IMP manufacturing and management strategy to ensure compliance with regulations and site set up processes